NEW YORK (GenomeWeb) – Agilent Technologies has announced a definitive agreement to acquire the assets of Boston-based laboratory management software firm iLab Solutions.

Under the terms of the agreement, Agilent will acquire substantially all assets of iLab, including its technology, intellectual property, product portfolio, and employees.

Privately held iLab provides cloud-based laboratory management services to universities, research hospitals, and research institutes around the world, the firm said in a statement. It has 70 employees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.